** Shares of Sihuan Pharmaceutical Holdings Group Ltd 0460.HK fall 3.4% to HK$0.56, extending losses for a second session
** Stock posts its biggest intraday pct drop since Jan 22
** Sihuan expects to record revenue of not less than 1.80 bln yuan ($248.25 mln) and a net loss of not more than 600 mln yuan for 2024, as generic drug business declines amid centralized procurement policy in the mainland and high R&D expenses
** This compares with a revenue of 1.86 bln yuan and a net loss of 54 mln yuan in 2023
** Hang Seng Commerce & Industry Index .HSNC rises 1.7%, healthcare index .HSCIH gains 0.5% and Hang Seng Index .HSI adds 1%
** Stock climbed 1.5% last year
($1 = 7.2507 Chinese yuan)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。